RenovoRx, Inc.

RNXT

NASDAQ

Healthcare

Biotechnology

Mountain View, CA, US10 employeesrenovorx.com

$1.02

+0.05(5.15%)

Mkt Cap $37M

$0.73

$1.42

52-Week Range

At a Glance

AI-generated

RenovoRx delivered strong revenue growth in FY2025 from increased adoption and repeat use of RenovoCath, but expanded operating losses reflect continued investment in commercial infrastructure amid ongoing clinical development.

Revenue breakdown: All Other Segments (100%).

8-K

RenovoRx, Inc. released full year 2025 financial results, key clinical and commercial updates, and details of its recent $10M financing to support upcoming milestones.

$37M

Market Cap

$928.1K

Revenue

-$11M

Net Income

Employees10

Fundamentals

How The Business Makes Money

Revenue by Segment

All Other Segments100%($1M)

Activity

What Changed Recently

Management Change

Mar 26, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On March 24,

Management Change

Feb 5, 2026

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. On February

Financial Results

Mar 29, 2026

| Results of Operations and Financial Condition. | |---|---| On March 30, 2026, RenovoRx, Inc. (the “Company”) issued a press release announcing its financial r

Material Agreement+3 More

Mar 22, 2026

. Entry into a Material Definitive Agreement. On March 17, 2026, RenovoRx, Inc., a Delaware corporation (the “Company”), entered into a securities purchase agre

Peer Companies

Company	Price	Change	Market Cap	P/E
MAIAMAIA Biotechnology, Inc.	$1.34	-0.37%	$52M	—
ELUTElutia Inc.	$1.18	+8.26%	$50M	0.9
ANVSAnnovis Bio, Inc.	$2.27	+7.31%	$45M	-2.1
PYPDPolyPid Ltd.	$4.38	-0.34%	$45M	-2.5
CELUCelularity Inc.	$1.34	+2.29%	$32M	-0.4
TVRDTvardi Therapeutics, Inc.	$3.03	+1.00%	$28M	-2.4
LTRNLantern Pharma Inc.	$1.59	+12.32%	$18M	-1.3
CALCCalciMedica, Inc.	$0.58	-1.94%	$9M	-328.3

Analyst View

Company Profile

CIK0001574094

ISINUS75989R1077

CUSIP75989R107

Phone650 284 4433

Address4546 El Camino Real, Mountain View, CA, 94022, US

SEC EDGAR